BUTYL ITRACONAZOLE (25 mg) (4-(4-{4-[4-({(2RS,4SR)-2-[(1H-1,2,4-Triazol-1-yl)methyl]-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl}methoxy)phenyl]piperazin-1-yl}phenyl)-2-butyl-2H-1,2,4-triazol-3(4H)-one )

In Stock

Ready to ship

Catalogue No.

1A11690

CAS No.

89848-51-1

Molecular Formula

C₃₅H₃₈Cl₂N₈O₄

Product Type

Pharmaceutical Analytical Impurities

$850.00

Shipping information

Click Here to learn more about Pharmaceutical Analytical Impurities (PAI). PAI products are different from official USP Reference Standards. This material is an Analytical Material and not a USP Reference Standard.

Additional information

Additional information

Current Lot Information

Current Lot:

F26860

CAS RN®

89848-51-1

Harmonized System (HS) Code *:

29349990

UN No:

N/A

NDC No:

N/A

Molecular Formula

C₃₅H₃₈Cl₂N₈O₄

Container Type:

VIAL

Base Control Substance (substance %):

N | A

Product Information

SDS:

USP Certificates/Product Information Sheets and Valid Use Dates

Lot No	USP Certificates/Product Information Sheets and Valid Use Dates	Valid Use Date	Country of Origin*	Material Origin*
F26860	1A11690-F26860	See Product Information Sheet	India	Chemical Synthesis


Lot No F26860	USP Certificates/Product Information Sheets and Valid Use Dates Chemical Synthesis
Valid Use Date See Product Information Sheet
Country of Origin* India
Material Origin* No data available

Lot No

F26860

USP Certificates/Product Information Sheets and Valid Use Dates

Chemical Synthesis

Valid Use Date

See Product Information Sheet

Country of Origin*

India

Material Origin*

No data available

Frequently bought together

BUTYL ITRACONAZOLE (25 mg) (4-(4-{4-[4-({(2RS,4SR)-2-[(1H-1,2,4-Triazol-1-yl)methyl]-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl}methoxy)phenyl]piperazin-1-yl}phenyl)-2-butyl-2H-1,2,4-triazol-3(4H)-one )

Catalogue No.

1A11690

CAS No.

89848-51-1

Molecular Formula

C₃₅H₃₈Cl₂N₈O₄

Product Type

Pharmaceutical Analytical Impurities

$850.00

OXINDOLE (25 mg) (1,3-Dihydro-2H-indol-2-one)

Catalogue No.

1A09990

CAS No.

59-48-3

Molecular Formula

C₈H₇NO

Product Type

Pharmaceutical Analytical Impurities

$475.00

INDOMETHACIN HYDRAZINE ANALOG (25 mg) (1-(4-Chlorobenzoyl)-1-(4-methoxyphenyl)-2-(4-chlorobenzoyl)hydrazide)

Catalogue No.

1A10010

CAS No.

402849-27-8

Molecular Formula

C₂₁H₁₆Cl₂N₂O₃

Product Type

Pharmaceutical Analytical Impurities

$450.00

DELTACORTINENE (25 mg) (17,21-Dihydroxypregna-1,4,9(11)-triene-3,20-dione)

BUTYL ITRACONAZOLE (25 mg) (4-(4-{4-[4-({(2RS,4SR)-2-[(1H-1,2,4-Triazol-1-yl)methyl]-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl}methoxy)phenyl]piperazin-1-yl}phenyl)-2-butyl-2H-1,2,4-triazol-3(4H)-one )

11ß-HYDROXYBOLDIONE (25 mg) (11β-Hydroxyandrosta-1,4-diene-3,17-dione)

AFATINIB AMINE (25 mg) ((S)-N?-(3-Chloro-4-fluorophenyl)-7-[(tetrahydrofuran-3-yl)oxy]quinazoline-4,6-diamine)

2-BROMOPALMITIC ACID (100 mg) (2-Bromohexadecanoic acid)

TETRACONTANE (100 mg) (Tetracontane)

HENEICOSANE (100 mg) (n-Heneicosane)

6-METHYL RISPERIDONE (25 mg) ((6RS)-3-{2-[4-(6-Fluorobenzisoxazol-3-yl)piperidin-1-yl]ethyl}-2,6-dimethyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one )

2-CHLORO BUPROPION HYDROCHLORIDE (25 mg) (2-(tert-Butylamino)-1-(2-chlorophenyl)propan-1-one hydrochloride)

ERYTHROMYCIN A N-OXIDE (25 mg) ((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-?-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[(3,4,6-trideoxy-3-dimethylamino-?-D-xylo-hexopyranosyl)oxy]oxacyclotetradecane-2,10-dione N-oxide)